MedPath

OVPLEX

OVPLEX

Discontinued
DIN Number

02234213

Drug Class

Human

Market Date

May 26, 1998

Company
HC

bio active canada ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02234213
AIG Number1332246001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (13)

ANGELICAE SINENSIS RADIXActive
Strength: 3 X
Monograph: ANGELICAE SINENSIS RADIX
APIS MELLIFICAActive
Strength: 12 X
Monograph: APIS MELLIFICA
BELLADONNAActive
Strength: 12 X
Monograph: BELLADONNA
CAULOPHYLLUM THALICTROIDESActive
Strength: 3 X
Monograph: CAULOPHYLLUM THALICTROIDES
CHARCOAL ACTIVATEDActive
Strength: 12 X
Monograph: CHARCOAL ACTIVATED
CIMICIFUGA RACEMOSAActive
Strength: 12 X
Monograph: CIMICIFUGA RACEMOSA
DIOSCOREA VILLOSAActive
Strength: 3 X
Monograph: DIOSCOREA VILLOSA
IODINEActive
Strength: 12 X
Monograph: IODINE
MAGNESIUM PHOSPHATE DIBASICActive
Strength: 12 X
Monograph: MAGNESIUM PHOSPHATE DIBASIC
OOPHORINUMActive
Strength: 6 X
Monograph: OOPHORINUM
PITUITARY POSTERIORActive
Strength: 6 X
Monograph: PITUITARY POSTERIOR
SEPIA OFFICINALIS LActive
Strength: 12 X
Monograph: SEPIA OFFICINALIS L
ZINCActive
Strength: 3 X
Monograph: ZINC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.